AI is transforming how biopharma generates evidence, from extracting insights from complex clinical data to scaling analyses that were previously too resource-intensive to pursue. But as AI expands what's possible, high-quality, validated data becomes even more critical. In this panel, experts from across the industry will discuss how trusted data and scientific rigor are enabling responsible AI adoption and accelerating oncology research. Topics include:
-
How high-quality, validated real-world data underpins trustworthy AI-enabled research
-
How transparent data validation is applied in practice to evaluate data quality and fitness for purpose
-
How biopharma teams are using AI to scale scientific analyses, uncover new insights, and extend researchers' capabilities
Watch to learn how biopharma is putting AI to work in oncology, what it takes to use these technologies responsibly, and how trusted data can turn AI's potential into actionable evidence.
